Philip P Connell Selected Research

Philip P Connell Research Topics

16	Neoplasms (Cancer) 01/2022 - 05/2004
4	Genomic Instability 01/2022 - 07/2013
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2021 - 06/2007
3	Neoplasm Metastasis (Metastasis) 10/2022 - 02/2012
2	Sarcoma (Soft Tissue Sarcoma) 12/2019 - 03/2010
2	Residual Neoplasm 01/2019 - 08/2017
2	Head and Neck Neoplasms (Head and Neck Cancer) 02/2016 - 05/2006
1	Colorectal Neoplasms (Colorectal Cancer) 10/2022
1	Hypersensitivity (Allergy) 10/2022
1	Pathologic Complete Response 01/2022
1	Triple Negative Breast Neoplasms 01/2022
1	Neuroblastoma 01/2019
1	Breast Neoplasms (Breast Cancer) 08/2017
1	Prostatic Neoplasms (Prostate Cancer) 07/2014
1	Carcinoma (Carcinomatosis) 03/2014
1	Necrosis 03/2010
1	Brain Neoplasms (Brain Tumor) 12/2007
1	Lung Neoplasms (Lung Cancer) 06/2007
1	Esophageal Neoplasms (Esophageal Cancer) 01/2007

8	DNA (Deoxyribonucleic Acid)IBA 10/2022 - 03/2014
4	Rad51 RecombinaseIBA 11/2016 - 05/2006
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2013
1	Biomarkers (Surrogate Marker)IBA 10/2022
1	PlatinumIBA 01/2022
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 01/2022
1	A-Form DNA (A-DNA)IBA 01/2022
1	Immune Checkpoint InhibitorsIBA 10/2021
1	Phosphotransferases (Kinase)IBA 01/2019
1	OTS167IBA 01/2019
1	AnthracyclinesIBA 08/2017
1	Phenobarbital (Luminal)FDA Link 08/2017
1	Nuclear Proteins (Protein, Nuclear)IBA 07/2014
1	Recombinases (Recombinase)IBA 07/2013
1	Carboplatin (JM8)FDA LinkGeneric 01/2007
1	Pemetrexed (MTA)FDA Link 01/2007
1	Hydroxyurea (Hydrea)FDA LinkGeneric 05/2006
1	Paclitaxel (Taxol)FDA LinkGeneric 05/2006
1	Fluorouracil (Carac)FDA LinkGeneric 05/2006
1	Peptides (Polypeptides)IBA 05/2004

10	Therapeutics 10/2022 - 05/2004
8	Radiotherapy 12/2019 - 05/2006
7	Drug Therapy (Chemotherapy) 10/2022 - 05/2006
2	Neoadjuvant Therapy 01/2022 - 06/2007
1	Immunotherapy 10/2021
1	Image-Guided Radiotherapy 02/2012
1	Surgical Amputation (Amputations) 03/2010
1	Chemoradiotherapy 03/2010
1	Induction Chemotherapy 05/2006